Safety and efficacy of statins
Lancet
.
2017 Mar 18;389(10074):1098.
doi: 10.1016/S0140-6736(17)30716-X.
Authors
Simon B Dimmitt
1
,
Hans G Stampfer
2
,
Jennifer H Martin
3
Affiliations
1
School of Medicine and Pharmacology, University of Western Australia, Subiaco, WA 6008, Australia. Electronic address: sdimmitt@bigpond.com.
2
School of Psychiatry and Clinical Neurosciences, University of Western Australia, Subiaco, WA 6008, Australia.
3
School of Medicine and Public Health, University of Newcastle, Callaghan, NSW, Australia.
PMID:
28322815
DOI:
10.1016/S0140-6736(17)30716-X
No abstract available
Publication types
Letter
Comment
MeSH terms
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors*
Treatment Outcome
Substances
Hydroxymethylglutaryl-CoA Reductase Inhibitors